InMed Pharmaceuticals (INM) Change in Acquisitions & Divestments (2019 - 2026)
InMed Pharmaceuticals (INM) posted quarterly Change in Acquisitions & Divestments of $16511.0 for Q1 2026, up 2.96% year-over-year from $16037.0 in Q1 2025, and up 293.21% quarter-over-quarter from $4199.0 in Q4 2025.
InMed Pharmaceuticals (INM) Change in Acquisitions & Divestments (2019 - 2026) Analysis & Trends
InMed Pharmaceuticals' Change in Acquisitions & Divestments history runs 6 years deep, the most recent figure standing at $16511.0 for Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments rose 2.96% year-over-year to $16511.0; the TTM figure through Mar 2026 stood at $43898.0 (up 10.83% YoY), while the FY2025 annual figure was $42270.0, changed 0.45% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $16511.0, up from $4199.0 in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $21324.0 in Q3 2024, with the low at -$431.0 in Q2 2024.
- The 4-year median for Change in Acquisitions & Divestments is $16274.0 (2025), against an average of $12601.9.
- Peak annual rise in Change in Acquisitions & Divestments reached 617.63% in 2025, while the deepest fall reached 24.34% in 2025.
- InMed Pharmaceuticals' Change in Acquisitions & Divestments stood at $21317.0 in 2023, then slumped by 87.44% to $2678.0 in 2024, then soared by 56.8% to $4199.0 in 2025, then soared by 293.21% to $16511.0 in 2026.
- Business Quant data shows INM's Change in Acquisitions & Divestments at $16511.0 in Q1 2026, $4199.0 in Q4 2025, and $20957.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | InMed Pharmaceuticals | 6.38 Mn | 1.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,511.00 |
| Mar 31, 2026 | 16,511.00 |
| Dec 31, 2025 | 4,199.00 |
| Dec 31, 2025 | 4,199.00 |
| Sep 30, 2025 | 20,957.00 |
| Sep 30, 2025 | 20,957.00 |
| Jun 30, 2025 | 2,231.00 |
| Jun 30, 2025 | 2,231.00 |
| Mar 31, 2025 | 16,037.00 |
| Mar 31, 2025 | 16,037.00 |
| Dec 31, 2024 | 2,678.00 |
| Dec 31, 2024 | 2,678.00 |
| Sep 30, 2024 | 21,324.00 |
| Sep 30, 2024 | 21,324.00 |
| Jun 30, 2024 | -431.00 |
| Jun 30, 2024 | -431.00 |
| Mar 31, 2024 | 21,196.00 |
| Mar 31, 2024 | 21,196.00 |
| Sep 30, 2023 | 21,317.00 |
| Sep 30, 2023 | 21,317.00 |